ak 2123 has been researched along with Oropharyngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatterjee, N; Huilgol, NG; Mehta, AR | 1 |
1 trial(s) available for ak 2123 and Oropharyngeal Neoplasms
Article | Year |
---|---|
An overview of the initial experience with AK-2123 as a hypoxic cell sensitizer with radiation in the treatment of advanced head and neck cancers.
Topics: Adult; Aged; Humans; Middle Aged; Neoplasm Staging; Oropharyngeal Neoplasms; Radiation-Sensitizing Agents; Remission Induction; Triazoles | 1996 |